What is Barclays's price target for NOV?

Barclays's latest stated price target for NOV Inc. (NOV) is $21, from its action on May 7, 2026.

What is Barclays's rating on NOV?

Barclays rates NOV Underweight, a bearish rating, as of May 7, 2026.

When did Barclays last change its view on NOV?

On May 7, 2026, Barclays downgrades to Underweight from Equal Weight, price target $21.

Barclays NOV price target and rating history

NOV Inc. (NOV) · Consumer Discretionary

Barclays rates NOV Inc. (NOV) Underweight with a $21 price target, as of its latest action on May 7, 2026. It has published 3 rating actions on NOV since October 2023, including 1 upgrade and 2 downgrades. Across 3 firms with a NOV price target in the last 12 months, the median target is $21. Barclays's target matches it.

Current rating: Underweight
Price target: $21
Median target, all firms: $21
Actions on NOV: 3

Barclays price target on NOV

Barclays price target on NOV, each point a stated target, October 2023 to May 2026.

Every Barclays rating on NOV

May 7, 2026
DowngradeBarclays downgrades to Underweight from Equal Weight, price target $21
Feb 4, 2026
UpgradeBarclays upgrades to Equal Weight from Underweight, price target $20
Oct 17, 2023
DowngradeBarclays downgrades to Underweight from Equal Weight, price target $20

How other firms rate NOV

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
Capital One	Overweight	$26	Jun 4, 2026
Barclays	Underweight	$21	May 7, 2026
RBC Capital Markets	Sector Perform	$21	Apr 14, 2026

Questions about Barclays and NOV

What is Barclays's price target for NOV?: Barclays's latest stated price target for NOV Inc. (NOV) is $21, from its action on May 7, 2026.
What is Barclays's rating on NOV?: Barclays rates NOV Underweight, a bearish rating, as of May 7, 2026.
When did Barclays last change its view on NOV?: On May 7, 2026, Barclays downgrades to Underweight from Equal Weight, price target $21.
How does Barclays's NOV target compare with other analysts?: Across 3 firms with a NOV price target in the last 12 months, the median target is $21. Barclays's target matches it.

More NOV rating histories

All Barclays ratings NOV news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.